BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24223161)

  • 1. Fhit delocalizes annexin a4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel.
    Gaudio E; Paduano F; Spizzo R; Ngankeu A; Zanesi N; Gaspari M; Ortuso F; Lovat F; Rock J; Hill GA; Kaou M; Cuda G; Aqeilan RI; Alcaro S; Croce CM; Trapasso F
    PLoS One; 2013; 8(11):e78610. PubMed ID: 24223161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells.
    Gaudio E; Paduano F; Ngankeu A; Ortuso F; Lovat F; Pinton S; D'Agostino S; Zanesi N; Aqeilan RI; Campiglia P; Novellino E; Alcaro S; Croce CM; Trapasso F
    Oncotarget; 2016 May; 7(21):29927-36. PubMed ID: 27166255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fhit, a tumor suppressor protein, induces autophagy via 14-3-3τ in non-small cell lung cancer cells.
    Lee TG; Jeong EH; Kim SY; Kim HR; Kim H; Kim CH
    Oncotarget; 2017 May; 8(19):31923-31937. PubMed ID: 28404875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FHIT protein enhances paclitaxel-induced apoptosis in lung cancer cells.
    Kim CH; Yoo JS; Lee CT; Kim YW; Han SK; Shim YS; Yoo CG
    Int J Cancer; 2006 Apr; 118(7):1692-8. PubMed ID: 16231322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FHIT
    Da Silva J; Jouida A; Ancel J; Dalstein V; Routhier J; Delepine G; Cutrona J; Jonquet A; Dewolf M; Birembaut P; Deslée G; Polette M; Nawrocki-Raby B
    J Pathol; 2020 Jun; 251(2):187-199. PubMed ID: 32237123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells.
    Nishizaki M; Sasaki J; Fang B; Atkinson EN; Minna JD; Roth JA; Ji L
    Cancer Res; 2004 Aug; 64(16):5745-52. PubMed ID: 15313915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
    Cantor JP; Iliopoulos D; Rao AS; Druck T; Semba S; Han SY; McCorkell KA; Lakshman TV; Collins JE; Wachsberger P; Friedberg JS; Huebner K
    Int J Cancer; 2007 Jan; 120(1):24-31. PubMed ID: 17019711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis by tumor suppressor FHIT via death receptor signaling pathway in human lung cancer cells.
    Deng WG; Nishizaki M; Fang B; Roth JA; Ji L
    Biochem Biophys Res Commun; 2007 Apr; 355(4):993-9. PubMed ID: 17328863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells.
    Druck T; Cheung DG; Park D; Trapasso F; Pichiorri F; Gaspari M; Palumbo T; Aqeilan RI; Gaudio E; Okumura H; Iuliano R; Raso C; Green K; Huebner K; Croce CM
    Cell Death Dis; 2019 Feb; 10(3):147. PubMed ID: 30770797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cells.
    Trapasso F; Pichiorri F; Gaspari M; Palumbo T; Aqeilan RI; Gaudio E; Okumura H; Iuliano R; Di Leva G; Fabbri M; Birk DE; Raso C; Green-Church K; Spagnoli LG; Venuta S; Huebner K; Croce CM
    J Biol Chem; 2008 May; 283(20):13736-44. PubMed ID: 18319262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression.
    Roz L; Andriani F; Ferreira CG; Giaccone G; Sozzi G
    Oncogene; 2004 Dec; 23(56):9102-10. PubMed ID: 15489891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased sensitivity to cisplatin in non-small cell lung cancer cell lines after FHIT gene transfer.
    Andriani F; Perego P; Carenini N; Sozzi G; Roz L
    Neoplasia; 2006 Jan; 8(1):9-17. PubMed ID: 16533421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ectogenous fragile histidine triad gene inhibits the malignant phenotype of human lung cancer cell line A549 in vitro and in vivo].
    Zhang LQ; Wang H; Lai BT; Yue WT; Zhan XP; Yang XH; Zhang CY; Zhang TM
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):333-6. PubMed ID: 15949315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of fragile histidine triad (FHIT) expression inhibits cell growth and induces apoptosis in cutaneous T-cell lymphoma cell line.
    Song X; Tian Z; Wang S; Peng Z; Feng J
    Cancer Invest; 2010 Dec; 28(10):1019-23. PubMed ID: 20690795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAIL-induced apoptosis of FHIT-negative lung cancer cells is inhibited by FHIT re-expression.
    Mirandola P; Gobbi G; Sponzilli I; Malinverno C; Cavazzoni A; Alfieri R; Petronini PG; Vitale M
    J Cell Physiol; 2009 Aug; 220(2):492-8. PubMed ID: 19418484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line.
    Cavazzoni A; Petronini PG; Galetti M; Roz L; Andriani F; Carbognani P; Rusca M; Fumarola C; Alfieri R; Sozzi G
    Oncogene; 2004 Nov; 23(52):8439-46. PubMed ID: 15361849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines.
    Roz L; Gramegna M; Ishii H; Croce CM; Sozzi G
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3615-20. PubMed ID: 11891319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma.
    Tomizawa Y; Nakajima T; Kohno T; Saito R; Yamaguchi N; Yokota J
    Cancer Res; 1998 Dec; 58(23):5478-83. PubMed ID: 9850082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
    Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
    Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connections between CHFR, the cell cycle, and chemosensitivity: Are they critical in cancer?
    Keller JA; Erson-Bensan AE; Petty EM
    Cancer Biol Ther; 2010 Nov; 10(9):942-4. PubMed ID: 21057211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.